[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578485":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":41,"responsibleParty":254,"collaborators":26,"id":256,"slug":257,"hasResults":258,"nctId":259,"briefTitle":260,"officialTitle":261,"acronym":26,"eligibilityCriteria":262,"healthyVolunteers":258,"sex":263,"minAge":264,"maxAge":26,"enrollmentInfo":265,"targetDuration":26,"studyType":268,"phases":269,"briefSummary":271,"conditions":272,"keywords":26,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":278,"lastUpdatePostDateStruct":279,"startDateStruct":282,"completionDateStruct":284,"leadSponsor":286,"locationsCount":287},{"fullName":5,"class":6},"BioStem Technologies","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"BR-AC plus Standard Care","EXPERIMENTAL","All subjects in the treatment group will receive sponsor-approved standard of care. Standard of care is defined as:\n\n* Sharp debridement,\n* Wound cleansing with a neutral, non-irritating and non-toxic solution,\n* Non-adherent wound contact layer followed by an alginate or foam pad to maintain a moist, warm wound bed, and\n* The UrgoK2™ dual compression system providing around 40 mmHg.\n\nUsing an appropriate size to cover the entire wound area, BR-AC should be applied directly to the wound surface following sharp debridement. It is recommended that the product be trimmed to fit the area of the wound with sterile scissors before application.",[13],"Other: BR-AC",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard Care","ACTIVE_COMPARATOR","All subjects in the control group will receive sponsor-approved standard of care. Standard of care is defined as:\n\n* Sharp debridement,\n* Wound cleansing with a neutral, non-irritating and non-toxic solution,\n* Non-adherent wound contact layer followed by an alginate or foam pad to maintain a moist, warm wound bed, and\n* The UrgoK2™ dual compression system providing around 40 mmHg.",[19],"Other: Standard Care",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"OTHER","BR-AC","BR-AC is an amnion layer, intermediate layer, and chorion layer placental membrane processed together with no separation of the layers. BR-AC is manufactured by BioStem Technologies, Inc. and is processed by the bioREtain method, which, briefly includes initial disinfection, processing with isotonic solutions, dehydration at 37-40°C, and electron beam sterilization.",[9],null,{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"Standard Care is defined as:\n\n* Sharp debridement,\n* Wound cleansing with a neutral, non-irritating and non-toxic solution,\n* Non-adherent wound contact layer followed by an alginate or foam pad to maintain a moist, warm wound bed, and\n* The UrgoK2™ dual compression system providing around 40 mmHg.",[15],[31],{"name":32,"affiliation":33,"role":34},"Bert Slade, MD","Independent","STUDY_DIRECTOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Nick McCoy","CONTACT","2144571996","nmccoy@biostemtech.com",[42,56,66,75,84,90,99,108,114,123,132,141,151,160,169,179,188,195,205,215,225,235,245],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":26},"Site 17","RECRUITING","Guntersville","Alabama","35976","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-86.29446,34.35823,{"lat":54,"lon":53},{"facility":57,"status":44,"city":58,"state":59,"zip":60,"country":48,"countryCode":49,"cosmosGeoPoint":61,"geoPoint":65,"contacts":26},"Site 2b","Castro Valley","California","94546",{"type":51,"coordinates":62},[63,64],-122.08635,37.6941,{"lat":64,"lon":63},{"facility":67,"status":44,"city":68,"state":59,"zip":69,"country":48,"countryCode":49,"cosmosGeoPoint":70,"geoPoint":74,"contacts":26},"Site 19b","Glendale","91204",{"type":51,"coordinates":71},[72,73],-118.25508,34.14251,{"lat":73,"lon":72},{"facility":76,"status":44,"city":77,"state":59,"zip":78,"country":48,"countryCode":49,"cosmosGeoPoint":79,"geoPoint":83,"contacts":26},"Site 36","Oxnard","93030",{"type":51,"coordinates":80},[81,82],-119.17705,34.1975,{"lat":82,"lon":81},{"facility":85,"status":44,"city":77,"state":59,"zip":86,"country":48,"countryCode":49,"cosmosGeoPoint":87,"geoPoint":89,"contacts":26},"Site 37","93036",{"type":51,"coordinates":88},[81,82],{"lat":82,"lon":81},{"facility":91,"status":44,"city":92,"state":59,"zip":93,"country":48,"countryCode":49,"cosmosGeoPoint":94,"geoPoint":98,"contacts":26},"Site 19","Palmdale","93551",{"type":51,"coordinates":95},[96,97],-118.11646,34.57943,{"lat":97,"lon":96},{"facility":100,"status":44,"city":101,"state":59,"zip":102,"country":48,"countryCode":49,"cosmosGeoPoint":103,"geoPoint":107,"contacts":26},"Site 02","San Francisco","94115",{"type":51,"coordinates":104},[105,106],-122.41942,37.77493,{"lat":106,"lon":105},{"facility":109,"status":44,"city":101,"state":59,"zip":110,"country":48,"countryCode":49,"cosmosGeoPoint":111,"geoPoint":113,"contacts":26},"Site 2a","94117",{"type":51,"coordinates":112},[105,106],{"lat":106,"lon":105},{"facility":115,"status":44,"city":116,"state":59,"zip":117,"country":48,"countryCode":49,"cosmosGeoPoint":118,"geoPoint":122,"contacts":26},"Site 04","Sylmar","91342",{"type":51,"coordinates":119},[120,121],-118.44925,34.30778,{"lat":121,"lon":120},{"facility":124,"status":44,"city":125,"state":59,"zip":126,"country":48,"countryCode":49,"cosmosGeoPoint":127,"geoPoint":131,"contacts":26},"Site 30","Torrance","90502",{"type":51,"coordinates":128},[129,130],-118.34063,33.83585,{"lat":130,"lon":129},{"facility":133,"status":44,"city":134,"state":59,"zip":135,"country":48,"countryCode":49,"cosmosGeoPoint":136,"geoPoint":140,"contacts":26},"Site 01","Vista","92081",{"type":51,"coordinates":137},[138,139],-117.24254,33.20004,{"lat":139,"lon":138},{"facility":142,"status":44,"city":143,"state":144,"zip":145,"country":48,"countryCode":49,"cosmosGeoPoint":146,"geoPoint":150,"contacts":26},"Site 34","Aventura","Florida","33180",{"type":51,"coordinates":147},[148,149],-80.13921,25.95648,{"lat":149,"lon":148},{"facility":152,"status":44,"city":153,"state":144,"zip":154,"country":48,"countryCode":49,"cosmosGeoPoint":155,"geoPoint":159,"contacts":26},"Site 27","Coral Gables","33134",{"type":51,"coordinates":156},[157,158],-80.26838,25.72149,{"lat":158,"lon":157},{"facility":161,"status":44,"city":162,"state":144,"zip":163,"country":48,"countryCode":49,"cosmosGeoPoint":164,"geoPoint":168,"contacts":26},"Site 20","Deerfield Beach","33442",{"type":51,"coordinates":165},[166,167],-80.09977,26.31841,{"lat":167,"lon":166},{"facility":170,"status":171,"city":172,"state":144,"zip":173,"country":48,"countryCode":49,"cosmosGeoPoint":174,"geoPoint":178,"contacts":26},"Site 33","WITHDRAWN","Fort Walton Beach","32547",{"type":51,"coordinates":175},[176,177],-86.61707,30.42059,{"lat":177,"lon":176},{"facility":180,"status":44,"city":181,"state":144,"zip":182,"country":48,"countryCode":49,"cosmosGeoPoint":183,"geoPoint":187,"contacts":26},"Site 35","Miami","33126",{"type":51,"coordinates":184},[185,186],-80.19366,25.77427,{"lat":186,"lon":185},{"facility":189,"status":190,"city":181,"state":144,"zip":191,"country":48,"countryCode":49,"cosmosGeoPoint":192,"geoPoint":194,"contacts":26},"Site 31","TERMINATED","33189",{"type":51,"coordinates":193},[185,186],{"lat":186,"lon":185},{"facility":196,"status":44,"city":197,"state":198,"zip":199,"country":48,"countryCode":49,"cosmosGeoPoint":200,"geoPoint":204,"contacts":26},"Site 06","O'Fallon","Illinois","62269",{"type":51,"coordinates":201},[202,203],-89.91121,38.59227,{"lat":203,"lon":202},{"facility":206,"status":44,"city":207,"state":208,"zip":209,"country":48,"countryCode":49,"cosmosGeoPoint":210,"geoPoint":214,"contacts":26},"Site 18","Boston","Massachusetts","02118",{"type":51,"coordinates":211},[212,213],-71.05977,42.35843,{"lat":213,"lon":212},{"facility":216,"status":44,"city":217,"state":218,"zip":219,"country":48,"countryCode":49,"cosmosGeoPoint":220,"geoPoint":224,"contacts":26},"Site 32","St Louis","Missouri","63128",{"type":51,"coordinates":221},[222,223],-90.19789,38.62727,{"lat":223,"lon":222},{"facility":226,"status":44,"city":227,"state":228,"zip":229,"country":48,"countryCode":49,"cosmosGeoPoint":230,"geoPoint":234,"contacts":26},"Site 16","Lake Success","New York","11042",{"type":51,"coordinates":231},[232,233],-73.71763,40.77066,{"lat":233,"lon":232},{"facility":236,"status":44,"city":237,"state":238,"zip":239,"country":48,"countryCode":49,"cosmosGeoPoint":240,"geoPoint":244,"contacts":26},"Site 38","Corpus Christi","Texas","78414",{"type":51,"coordinates":241},[242,243],-97.39638,27.80058,{"lat":243,"lon":242},{"facility":246,"status":44,"city":247,"state":238,"zip":248,"country":48,"countryCode":49,"cosmosGeoPoint":249,"geoPoint":253,"contacts":26},"Site 03","Fort Worth","76104",{"type":51,"coordinates":250},[251,252],-97.32085,32.72541,{"lat":252,"lon":251},{"type":255,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100578485","non-healing-venous-leg-ulcers-treated-with-standard-care-with-or-without-br-ac-100578485",false,"NCT06811909","Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC","A Prospective, Multicenter, Randomized, Controlled Trial of Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC","Inclusion Criteria:\n\n1. Patient has signed the informed consent form.\n2. Male or female patient at least 18 years of age or older, as of the date of the screening visit.\n3. Has a VLU between the knee and ankle (at or above the malleoli), with a surface area in the range of ≥ 2.0 cm2 and ≤ 20.0 cm2 when measured by the investigator staff at the screening visit using the eKare device post debridement.\n\n   1. If the subject presents with \\> 1, but ≤ 3 VLU on the same leg, the largest ulcer will be selected as the target ulcer.\n   2. If the target ulcer is \\\u003C 1cm from another VLU, the ulcers should be traced as a single target ulcer provided at least one of the ulcers is at least 2.0 cm2 in area and the total surface area of the VLUs is ≤ 20.0 cm2.\n4. Target ulcer involves a full-thickness skin loss, but without exposure of tendon, muscle, or bone.\n5. Target ulcer duration ≥ 4 weeks but ≤ 52 weeks (12 months).\n6. Venous insufficiency confirmed by duplex Doppler ultrasound examining valvular or venous incompetence.\n\n   a. Availability of a complete report of a previous examination performed 12 months of screening will be acceptable, and this examination would not be required to be repeated.\n7. Arterial supply adequacy confirmed by any one of the following:\n\n   1. Great toe pressure ≥ 50 mm\u002FHg\n   2. Systolic blood pressure Ankle Brachial Index (ABI) in the range ≥ 0.80 ≤ 1.10\n   3. TcPO2 ≥ 40 mmHg from the foot\n8. Willing to follow all instructions given by the Investigator, return for all visits, and adhere to compression protocols while on the study.\n\nExclusion Criteria:\n\n1. A target ulcer of non-venous etiologies (e.g., sickle cell anemia, necrobiosis lipoidica diabeticorum, pyoderma gangrenosum, vasculopathic or vasculitic).\n2. Acute Deep Vein Thrombosis (DVT), defined as the first 10 days from onset of symptoms, or any DVT for which compression is considered by the Investigator to be contraindicated.\n3. Clinical evidence of ulcer bed infection, or infected hardware.\n4. Documented history of osteomyelitis at the target ulcer location within six (6) months preceding the screening visit.\n5. Refusal or inability to tolerate compression therapy.\n6. Pregnant women.\n7. Women of child-bearing potential who are unwilling to avoid pregnancy or use an effective form of birth control.\n8. Hemoglobin A1c (HbA1c) level is \\> 12% (108 mmol\u002Fmol).\n9. Current therapy with systemic antibiotics.\n10. Current therapy with cytotoxic agents.\n11. Current therapy with chronic (\\> 10 days) oral corticosteroids.\n12. Current therapy with TNFα inhibitors other than Trental® (pentoxifylline).\n13. Has tested positive for Human Immunodeficiency Virus (HIV) or has Acquired Immune Deficiency Syndrome (AIDS).\n14. Has malignancy or history of cancer in the preceding 5 years other than non-melanoma skin cancer.\n15. Currently on dialysis or planning to start dialysis.\n16. Is currently enrolled or participated in another device, drug, or biological trial within 30 days of screening.\n17. Therapy of the target ulcer with other birth tissue products, autologous skin graft, Apligraf®, or Dermagraft® within 30 days preceding the screening visit.\n18. Therapy of the target ulcer with topical growth factors within thirty (30) days preceding the screening visit.\n19. Any previous use of Vendaje®, Vendaje AC®, AmnioWrap2® applied to the target ulcer.","ALL","18 Years",{"count":266,"type":267},60,"ESTIMATED","INTERVENTIONAL",[270],"NA","This study examines a patient population with a non-healing, non-infected venous leg ulcer (VLU) having adequate arterial perfusion with confirmed venous reflux. It is hypothesized that weekly applications of the human placental allograft BioREtain® Amnion Chorion (BR-AC) applied to a non-healing VLU will result in a higher proportion of wounds showing complete healing within 12 weeks of initiating therapy, compared to standard care alone.\n\nThis study has a crossover period, where subjects on standard care alone who do not achieve complete healing within 12 weeks of initiating therapy will be allowed to crossover to receive BR-AC over 12 additional weeks, to evaluate if their wound can achieve complete healing.",[273,274,275,276,277],"Non-infected Venous Leg Ulcer","Venous Leg Ulcer","Venous Insufficiency","Venous Stasis","Venous Reflux","2026-01-21",{"date":280,"type":281},"2026-01-23","ACTUAL",{"date":283,"type":281},"2025-02-14",{"date":285,"type":267},"2026-10",{"name":5,"class":6},23]